The risk or severity of adverse effects can be increased when Perindopril is combined with Tiaprofenic acid. Alfuzosin may increase the hypotensive activities of Perindopril. The serum concentration of Clomipramine can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Nabumetone. The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Perindopril. Bemiparin may increase the hyperkalemic activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Terazosin. Perindopril may increase the hypotensive activities of Indenolol. Amobarbital may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Labetalol is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Celecoxib. Debrisoquin may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Tolfenamic Acid. The serum concentration of Esmirtazapine can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Empagliflozin. The risk or severity of adverse effects can be increased when Telmisartan is combined with Perindopril. Nicorandil may increase the hypotensive activities of Perindopril. Avanafil may increase the antihypertensive activities of Perindopril. The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Perindopril. Nadroparin may increase the hyperkalemic activities of Perindopril. The metabolism of Verapamil can be decreased when combined with Perindopril. Perindopril may increase the hypotensive activities of Sitaxentan. The serum concentration of Cabergoline can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Sevoflurane is combined with Perindopril. Mebanazine may increase the hypotensive activities of Perindopril. The serum concentration of Prucalopride can be increased when it is combined with Perindopril. Yohimbine may decrease the antihypertensive activities of Perindopril. Perindopril may increase the orthostatic hypotensive activities of Duloxetine. The risk or severity of adverse effects can be increased when Triamterene is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Quetiapine. Perindopril may increase the hypotensive activities of Rescinnamine. Piretanide may increase the hypotensive activities of Perindopril. The serum concentration of Perindopril can be decreased when it is combined with Lanthanum carbonate. The risk or severity of adverse effects can be increased when Irbesartan is combined with Perindopril. Candoxatril may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Fimasartan is combined with Perindopril. Minaprine may increase the hypotensive activities of Perindopril. Caroxazone may increase the hypotensive activities of Perindopril. Perindopril may increase the hypotensive activities of Lofexidine. The risk or severity of adverse effects can be increased when Metolazone is combined with Perindopril. Dapoxetine may increase the orthostatic hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Apomorphine is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Diclofenamide. Hydracarbazine may increase the hypotensive activities of Perindopril. The metabolism of Tacrolimus can be decreased when combined with Perindopril. Harmaline may increase the hypotensive activities of Perindopril. The serum concentration of Digoxin can be increased when it is combined with Perindopril. The metabolism of Perindopril can be increased when combined with St. John's Wort. Nitroaspirin may decrease the antihypertensive activities of Perindopril. The risk or severity of adverse effects can be increased when Eprosartan is combined with Perindopril. The risk or severity of adverse effects can be increased when Imidapril is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Quinapril. The risk or severity of adverse effects can be increased when Isradipine is combined with Perindopril. The risk or severity of adverse effects can be increased when Carbetocin is combined with Perindopril. Perindopril may increase the hypotensive activities of Oxprenolol. Aliskiren may increase the hyperkalemic activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Papaverine. Safrazine may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Benazepril is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Teriflunomide. The risk or severity of adverse effects can be increased when Perindopril is combined with Valdecoxib. The risk or severity of adverse effects can be increased when Perindopril is combined with Droxicam. Cryptenamine may increase the hypotensive activities of Perindopril. Ardeparin may increase the hyperkalemic activities of Perindopril. Perindopril may increase the hypotensive activities of Tetrahydropalmatine. Perindopril may increase the hypotensive activities of Tolazoline. Pargyline may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Perindopril. Perindopril may increase the hypotensive activities of Ferulic acid. The serum concentration of Everolimus can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Phenylbutazone. Barbital may increase the hypotensive activities of Perindopril. The serum concentration of Conjugated estrogens can be decreased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Meloxicam. Pheniprazine may increase the hypotensive activities of Perindopril. Perindopril may increase the hypotensive activities of Cafedrine. The serum concentration of Perindopril can be decreased when it is combined with Tipranavir. The risk or severity of adverse effects can be increased when Saxagliptin is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Balsalazide. The serum concentration of Amoxapine can be increased when it is combined with Perindopril. Perindopril may increase the hypotensive activities of Pentolinium. The risk or severity of adverse effects can be increased when Perindopril is combined with Indapamide. Iloprost may increase the hypotensive activities of Perindopril. Moxonidine may increase the hypotensive activities of Perindopril. The serum concentration of Cyclobenzaprine can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Antipyrine. The risk or severity of adverse effects can be increased when Perindopril is combined with Leflunomide. The risk or severity of adverse effects can be increased when Perindopril is combined with SRT501. The risk or severity of adverse effects can be increased when Perindopril is combined with Mizoribine. The risk or severity of adverse effects can be increased when Thalidomide is combined with Perindopril. Perindopril may increase the hypotensive activities of Alprenolol. Phenobarbital may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Isosorbide Mononitrate. The serum concentration of Diethylstilbestrol can be decreased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Evening primrose oil. The risk or severity of adverse effects can be increased when Perindopril is combined with Flurbiprofen. The risk or severity of adverse effects can be increased when Isoflurane is combined with Perindopril. The serum concentration of Naloxegol can be increased when it is combined with Perindopril. Perindopril may increase the hypotensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Perindopril is combined with Cyclophosphamide. The risk or severity of adverse effects can be increased when Perindopril is combined with Bufexamac. Perindopril may increase the hypotensive activities of Vincamine. Furazolidone may increase the hypotensive activities of Perindopril. Rilmenidine may increase the hypotensive activities of Perindopril. Perindopril may increase the nephrotoxic activities of Sodium phosphate. The risk or severity of adverse effects can be increased when Forasartan is combined with Perindopril. The serum concentration of Abacavir can be decreased when it is combined with Perindopril. Hexobarbital may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Clonidine is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Methyldopa. The therapeutic efficacy of Perindopril can be decreased when used in combination with Acemetacin. The serum concentration of Triazolam can be increased when it is combined with Perindopril. Perindopril may increase the hypotensive activities of Macitentan. The serum concentration of Enfuvirtide can be increased when it is combined with Perindopril. Selegiline may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Olsalazine. The risk or severity of adverse effects can be increased when Perindopril is combined with Indomethacin. The risk or severity of adverse effects can be increased when Perindopril is combined with Pethidine. Phenelzine may increase the hypotensive activities of Perindopril. Perindopril may increase the hypotensive activities of Cyclopenthiazide. The serum concentration of Zidovudine can be decreased when it is combined with Perindopril. The serum concentration of Methylergometrine can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Isoxsuprine. Indoramin may increase the hypotensive activities of Perindopril. Hydroflumethiazide may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Nimodipine is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Cilazapril. The risk or severity of adverse effects can be increased when Perindopril is combined with Masoprocol. The serum concentration of Pazopanib can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Diclofenac.